As in EATL, activating mutations in components of the JAK-STAT pathway are frequently observed (76–83% of cases), with higher frequencies of mutations in JAK3 and STAT5B reported in MEITL than in EATL [36,40,62,65]. This evidence concerns the gene JAK3 and enteropathy-associated T-cell lymphoma.